Literature DB >> 19593728

Human adenovirus-36 antibody status is associated with obesity in children.

Richard L Atkinson1, Insil Lee, Hye-Jung Shin, Jia He.   

Abstract

BACKGROUND: Human adenovirus-36 (Ad-36) is thought to induce obesity by a direct effect of the viral E4orf1 gene on lipogenic enzymes in host adipocytes. Ad-36 prevalence is 30% in obese adults, but prevalence has not been reported in childhood obesity.
OBJECTIVES: To determine the prevalence of Ad-36 infection in obese Korean children (age 14.8 +/- 1.9; range 8.3-6.3 years); correlation of infection with BMI z-score and other obesity measures.
METHODS: Blood was drawn at the annual school physical exam or clinic visit; Ad-36 status was determined by serum neutralization assay; and routine serum chemistry values.
RESULTS: A total of 30% of subjects were positive (N = 25) for Ad-36; 70% were negative (N = 59). Significantly higher BMI z-scores (1.92 vs. 1.65, p < 0.01) and waist circumferences (96.3 vs. 90.7 cm, p = 0.05) were found in infected versus uninfected children. Cardiovascular risk factors were not significantly different.
CONCLUSIONS: Ad-36 infection is common in obese Korean children and correlates highly with obesity. Ad-36 may have played a role in the obesity and Type 2 diabetes epidemic in children.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19593728     DOI: 10.3109/17477160903111789

Source DB:  PubMed          Journal:  Int J Pediatr Obes        ISSN: 1747-7166


  30 in total

1.  Mini-review: Obesity in Caribbean Youth.

Authors:  E A Traboulay; O P-A Hoyte
Journal:  West Indian Med J       Date:  2015-04-01       Impact factor: 0.171

Review 2.  Infectious and Environmental Influences on the Obesity Epidemic.

Authors:  Lili Huo; Jasmine Lyons; Dianna J Magliano
Journal:  Curr Obes Rep       Date:  2016-09

3.  Adenovirus 36 antibody detection: Improving the standard serum neutralization assay.

Authors:  Cynthia L Chappell; Mary Dickerson; R Sue Day; Olga Dubuisson; Nikhil V Dhurandhar
Journal:  J Virol Methods       Date:  2016-11-05       Impact factor: 2.014

4.  Adenovirus 36, adiposity, and bone strength in late-adolescent females.

Authors:  Emma M Laing; Ralph A Tripp; Norman K Pollock; Clifton A Baile; Mary Anne Della-Fera; Srujana Rayalam; Stephen M Tompkins; Deborah A Keys; Richard D Lewis
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

5.  Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children.

Authors:  P K Berger; N K Pollock; E M Laing; S J Warden; K M Hill Gallant; D B Hausman; R A Tripp; L D McCabe; G P McCabe; C M Weaver; M Peacock; R D Lewis
Journal:  J Clin Endocrinol Metab       Date:  2014-06-13       Impact factor: 5.958

6.  Gene expression profile in human skeletal muscle cells infected with human adenovirus type 36.

Authors:  Zhong Q Wang; Yongmei Yu; Xian H Zhang; Jianhua Qin; Elizabeth Floyd
Journal:  J Med Virol       Date:  2012-08       Impact factor: 2.327

7.  Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study.

Authors:  M A Sabin; D Burgner; R L Atkinson; Z Pei-Lun Lee; C G Magnussen; M Cheung; M Kähönen; T Lehtimäki; E Jokinen; T Laitinen; N Hutri-Kähönen; J S A Viikari; M Juonala; O T Raitakari
Journal:  Int J Obes (Lond)       Date:  2015-06-09       Impact factor: 5.095

8.  Adenovirus-36 antibody status & BMI comparison among obese Missouri adolescents.

Authors:  Aneesh K Tosh; Amelia Broy-Aschenbrenner; Jasmine El Khatib; Bin Ge
Journal:  Mo Med       Date:  2012 Sep-Oct

9.  Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity.

Authors:  Behrouz Salehian; Stephen J Forman; Fouad R Kandeel; Denise E Bruner; Jia He; Richard L Atkinson
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

10.  Adenovirus 36 infection: a role in dietary intake and response to inpatient weight management in obese girls.

Authors:  H Zamrazilová; I Aldhoon-Hainerová; R L Atkinson; L Dušátková; B Sedláčková; Z P Lee; M Kunešová; M Hill; V Hainer
Journal:  Int J Obes (Lond)       Date:  2015-08-25       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.